US Broker Ratings

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Look at Growth Potential and Strategic Positioning

Pacira BioSciences, Inc. (NASDAQ: PCRX), a notable player in the healthcare sector, specializes in the development and commercialization of non-opioid pain management solutions. As the opioid crisis continues to challenge..

MannKind Corporation (MNKD) Stock Analysis: Investor Outlook on a Biotech with Over 100% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a dynamic player in the biotechnology sector, is catching the attention of investors with its promising growth trajectory and innovative solutions for chronic diseases. With a..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specializes in developing and marketing critical bioproduction products and services for the cell and gene therapy (CGT) industry...

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges

Teladoc Health, Inc. (NASDAQ: TDOC) has been a transformative force in the healthcare sector, offering a wide array of virtual healthcare services. With its headquarters in New York, Teladoc operates..

NeoGenomics, Inc. (NEO): Investor Outlook with a Spotlight on 24.51% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $2.06 billion, this Fort Myers-based company is..

Immunocore Holdings plc (IMCR) Investor Outlook: Exploring a Potential 96% Upside in Biotech Innovation

Immunocore Holdings plc (NASDAQ: IMCR) stands at the forefront of the biotechnology industry, making waves with its innovative approaches to immunotherapy. With a market cap of $1.65 billion, this UK-based..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unpacking a 241.90% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology firm based in Singapore, operates at the cutting edge of RNA medicine development. The company’s focus on designing innovative treatments for both..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 222% Upside Potential in Biotech Innovation

Investors with an eye on emerging biotechnologies may want to take a closer look at Ocular Therapeutix, Inc. (NASDAQ: OCUL), a company making significant strides in the healthcare sector. With..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A Promising Healthcare Play with 8.74% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) represents an intriguing opportunity for investors looking to tap into the healthcare sector. With a market capitalization of $2.09 billion and a current stock..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Healthy 12% Upside Potential for Investors

The Pennant Group, Inc. (NASDAQ: PNTG), a healthcare services provider based in Eagle, Idaho, has been making waves in the medical care facilities industry. With a market capitalization of $1.4..

GeneDx Holdings Corp. (WGS) Stock Analysis: Strong Buy Ratings and 20% Potential Upside

Investors looking for opportunities in the healthcare sector should take a close look at GeneDx Holdings Corp. (WGS), a company making significant strides in the genomics space. With a market..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook on a Promising Biotech with 87% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company at the forefront of developing treatments for serious and rare diseases, has caught the attention of investors with its promising portfolio and..

Astrana Health Inc. (ASTH) Stock Analysis: Poised for Growth with 37% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is capturing the attention of investors with its impressive revenue growth and significant potential upside. With a market..

SS Innovations International (SSII) Stock Analysis: Unveiling a 77% Upside Potential in the Thriving Surgical Robotics Market

SS Innovations International, Inc. (SSII) stands as a noteworthy contender in the healthcare sector, specifically within the burgeoning medical devices industry. With its headquarters in Gurugram, India, the company is..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating Challenges with a 1.63% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a notable player in the healthcare sector, specifically within the health information services industry. Based in the United States, the company is known..

10x Genomics, Inc. (TXG)

⚠️ No article content returned.

..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unveiling a 37% Potential Upside for Savvy Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry, stands out in the current market landscape with..

Travere Therapeutics, Inc. (TVTX): Growth Potential in Rare Disease Market with Strong Buy Ratings

Travere Therapeutics, Inc. (NASDAQ: TVTX) is emerging as a noteworthy player in the biotechnology sector, with its focus on developing therapies for rare kidney and metabolic diseases. With a current..

Neogen Corporation (NEOG) Stock Analysis: Is the Healthcare Innovator’s 9.24% Upside Within Reach?

Investors with a keen eye on the healthcare sector may find Neogen Corporation (NASDAQ: NEOG) an intriguing prospect. As a key player in the medical devices industry, Neogen specializes in..

Arcutis Biotherapeutics, Inc. (ARQT): Investor Outlook on a Potential 33% Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a rising star in the biotechnology sector, is capturing investor attention with its strong revenue growth and promising market prospects. Headquartered in Westlake Village, California,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds